Pfizer Inc.
Therapeutic Nanoparticles Comprising A Therapeutic Agent And Methods of Making And Using Same

Last updated:

Abstract:

The present disclosure generally relates to nanoparticles comprising an endo-lysosomal escape agent, a nucleic acid, and a polymer. Other aspects include methods of making and using such nanoparticles.

Status:
Application
Type:

Utility

Filling date:

18 Feb 2021

Issue date:

26 Aug 2021